THE TRIFECTA: A NOVEL COMBINATORIAL THERAPY SPARES IMMUNE CELLS WHILE INDUCING IMMUNOGENIC CELL DEATH IN HUMAN MAMMARY ADENOCARCINOMA AND MOUSE MAMMARY CARCINOMA
According to U.S. Breast Cancer Statistics, about 1 in 8 U.S. women will develop invasive breast cancer during their lifetime. Chemotherapeutics that are used on patients currently often lead to tumor resistance, bone marrow suppression and cachexia. This study evaluated a novel combination of three...
Other Authors: | Motii, Youssef (author) |
---|---|
Format: | Others |
Language: | English |
Published: |
Florida Atlantic University
|
Subjects: | |
Online Access: | http://purl.flvc.org/fau/fd/FA00013606 |
Similar Items
-
S-adenosyl-L-methionine decarboxylase activity in mouse mammary adenocarcinomas and normal mouse mammary tissue
by: Auger, Elizabeth A.
Published: (2011) -
Wogonin suppresses stem cell-like traits of CD133 positive osteosarcoma cell via inhibiting matrix metallopeptidase-9 expression
by: Do Luong Huynh, et al.
Published: (2017-06-01) -
Colorectal Adenocarcinoma Cell Culture in a Microfluidically Controlled Environment with a Static Molecular Gradient of Polyphenol
by: Roman G. Szafran, et al.
Published: (2021-05-01) -
A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway
by: Hailong Zhang, et al.
Published: (2016-05-01) -
Sustained Cytotoxicity of Wogonin on Breast Cancer Cells by Encapsulation in Solid Lipid Nanoparticles
by: Jong-Suep Baek, et al.
Published: (2018-03-01)